Latest Headlines

Latest Headlines

SynapDx, Broad Institute align to make autism Dx with next-gen sequencing

SynapDx and the Broad Institute of Harvard and MIT have joined forces to take on the area of autism diagnostics using next-generation sequencing.

SynapDx and the Broad Institute link to use next-gen sequencing for better autism tests

Startup SynapDx will team with the famed Broad Institute of Harvard and MIT to advance next-generation DNA sequencing for more accurate and clinically useful autism diagnostic tools.

FierceMedicalDevices' 2013 Fierce 15

Believe us when we tell you this: The 15 fiercest medical device and diagnostics companies of 2013 rival our first annual roundup from 2012 in terms of innovation, drive and market-changing...

Google leads SynapDx's $15.4M funding round

SynapDx has wrapped up $15.4 million in new funding to help advance a 660-patient study of the company's autism blood test that began enrollment in April. The Massachusetts startup turned to Google Ventures to lead the round.

SynapDx, Illumina ally to develop autism diagnostic tools

SynapDx is allying with gene sequencer Illumina to explore development of diagnostic tools for autism spectrum disorders and other "opportunities in neurodevelopment."

Autism blood Dx might focus on fat metabolism marker

A team of Canadian and U.S. researchers believe they've come up with a possible blood test option for autism, something that could help spot a unique pattern of fat metabolism blood markers found in a sizeable minority of children with the disorder.

SynapDx attracts $6M for large autism Dx study

SynapDx, developer of a blood diagnostic test for autism spectrum disorders, nailed down $6 million in new venture funding, the company disclosed Dec. 11. Having the financial backing enables executives to proceed with a 600-patient prospective multicenter clinical study for the test.

SynapDx to commence autism Dx trials in early 2013

SynapDx plans to begin clinical trials early next year for a blood test that could lead to the early detection of autism.

Altura Medical lands $20M in VC

California-based Altura Medical has rounded up $20 million in Series A financing. The early-stage manufacturer is developing devices and methods for the treatment of abdominal aortic aneurysms, a